Nxera Pharma, previously known as Sosei Heptares or the Sosei Group, has entered a collaboration and licensing agreement with Antiverse to design antibodies for G-protein coupled receptors (GPCRs).

Black holes are points in space that are so dense they create deep gravity sinks. Beyond a certain region, not even light can escape the powerful tug of a black hole's gravity. And anything that ...

In the ever-evolving realm of contemporary office design, Studio Deshi’s latest venture, ‘A Square Peg in a Round Hole,’ stands as a pioneering example of innovation. Located in the bustling city of ...

Bispecific antibodies (bsAbs) are designed to recognise two different epitopes and, compared to current monovalent antibody therapeutics ... For instance, in the ‘knob-in-hole’ approach ...

pairing the science with its antibody design platform to tailor a next-gen ADC pipeline. BigHat used its AI- and machine learning-powered platform, dubbed Milliner, to design an antibody to dress ...

The collaboration combines Antiverse’s generative AI antibody design expertise, including its proprietary machine-learning-generated ‘epitope-specific libraries,’ with Nxera’s NxWave™ platform, a ...

Tokyo, Japan and London and Cardiff, UK, 5 November 2024 – Nxera Pharma (“Nxera”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – and Antiverse, a techbio company designing ...